Vetsys Pharmaceutical
Vetsys Pharmaceutical
Explore our industry-certified bio-pharmaceutical agents, functional ointments, and specialty topical formulations engineered to meet precise clinical benchmarks.
The global dermatological landscape is shifting from superficial cosmetic enhancements to clinically proven skin barrier therapies. As a premier partner, Zhengzhou Vetsys Pharmaceutical Co., Ltd. (Vetsys) leverages decades of high-precision pharmaceutical expertise to design and manufacture superior custom OEM skin care solutions.
Founded in 2005 with a robust registered capital of 30 million RMB, Vetsys operates at the intersection of biochemical research and state-of-the-art topical drug delivery systems. Our compliance with international Good Manufacturing Practices (GMP) ensures that every formulation—whether it is a specialized transdermal ointment, a soothing veterinary therapeutic, or a high-performance topical barrier cream—is produced under strict sterile conditions.
This pharmaceutical pedigree is what sets us apart. Standard cosmetic manufacturing facilities lack the rigorous bio-burden controls, trace analytical verification, and stability testing standards that are natural to a GMP-certified pharmaceutical manufacturer. We offer brands a distinct Information Gain advantage through scientifically validated, clean-label ingredients, structural packaging stability, and unmatched regulatory compliance.
The macro-dynamics driving global B2B procurement, from molecular innovations to regulatory pressure.
Modern consumers demand target-specific efficacy. Advanced transdermal delivery methods, such as micro-encapsulation, liposomal suspensions, and lipid nanoparticles, ensure active ingredients cross the lipid barrier to optimize cellular repair.
With changing FDA, EMA, and NMPA standards, clean-label manufacturing is no longer optional. B2B buyers require complete trace metal testing, toxicological reports, and GMP documentation to secure international market clearance.
The boundaries between human clinical cosmetics and animal topical care have blurred. Veterinary skincare now demands cosmetic-grade stability, natural extracts, and advanced anti-inflammatory agents to preserve the epidermal integrity of companion animals.
Underpinned by independent science, specialized research units, and advanced processing mechanisms.
At Vetsys, we believe that true differentiation lies in chemical innovation. We have established an independent research institute equipped with five specialized laboratories staffed by a team of world-class scientists and formulation engineers. This capability allows us to adapt swiftly to the evolving requirements of clinical dermatology and animal therapeutics.
Our core R&D focuses on solving stability issues associated with active biomolecules like Alpha Lipoic Acid, lipids, and enzymatic granules. By ensuring zero oxidation during the manufacturing cycle, our formulations retain maximum efficacy throughout their shelf life. This is why our 3oz Wound Care Repair Triple Antibiotic Ointment and topical veterinary solutions remain trusted globally.
Vetsys' custom manufacturing plant covers the entire value chain—from packaging raw mold injection to chemical mixing, vacuum emulsification, assembly, and drying. This integrated control prevents cross-contamination, ensuring absolute compliance with global pharmaceutical and cosmetic hygiene standards.
Below is the technological blueprint of our physical infrastructure, verifying our capacity to design, scale, and deliver complex private label skincare packaging and formulations under one roof.
Quality is not a final milestone; it is the starting point of our process. Vetsys has developed a comprehensive quality control system monitoring every node of raw material intake, synthesis, manufacturing, packaging design, and logistics. Our commitment to strict GMP compliance guarantees that all solutions are formulated under class-10,000 cleanrooms and tested via high-performance liquid chromatography (HPLC) and microbial challenge assays before leaving the plant.
By operating with high-grade testing protocols, we help international brands navigate FDA, CE, and country-specific cosmetic/veterinary regulations with confidence. This rigorous methodology has helped Vetsys establish trust across global markets, achieving domestic sales of over USD 20 million by 2015 and supporting clients in North America, Europe, and Southeast Asia.
The modern consumer demands environmentally conscious practices. As a responsible global OEM supplier, Vetsys actively implements green production strategies. We utilize closed-loop extraction processes that reduce wastewater discharge, source biodegradable raw materials, and optimize our injection and blow-molding packaging systems to utilize recycled polymer matrices.
By minimizing our carbon footprint and offering eco-certified alternatives, we empower cosmetic brands to appeal to eco-conscious consumers. This dual focus on efficacy and sustainability is the foundation of our corporate vision.
Our structured evolution map for development, scaling, and intelligent biochemical formulation.
Integrating bio-mimetic lipid membranes with advanced peptides to mimic natural skin barriers. Ideal for wound care ointments and clinical barrier protection lines.
Transitioning molecular delivery from standard macro-emulsions to nano-emulsified vectors, expanding transdermal absorption limits for deep cellular therapy.
Developing customized extrusion and blow-molding frameworks from plant-derived bioplastics to achieve 100% microplastic-free topical product packaging solutions.
Expert technical insights to help procurement managers and research teams make informed decisions.
Explore our expanded formulation portfolio supporting oral therapeutics, high-purity feed matrices, and functional topical solutions.
